Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT01265576
Show Display Options
Rank Status Study
1 Active, not recruiting Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC)
Condition: HCC
Interventions: Drug: Sorafenib;   Drug: VT-122 (propranolol plus etodolac);   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.